JPRN-UMIN000014344已完成4 期
Efficacy and safety of concomitant use of three immunosuppressant therapy for anti-MDA5 antibody-positive dermatomyositis with interstitial pneumonia - Therapy for anti-MDA5 antibody positive interstitial pneumonia
Kyoto University Graduate School of Medicine0 个研究点目标入组 25 人开始时间: 2014年7月1日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 16years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who have active tuberculosis or hepatitis B virus infection. Patients who have malignancy when dermatomyositis is diagnosed. Patients under 16 years old.
研究者
相似试验
尚未招募
不适用
Comparison of two types of standard Three drug regimen treatments in dyspepsia due to H. pylori infection.CTRI/2020/03/024057DR Rajendra Prasad Government Medical College Kangra at Tanda
进行中（未招募）
3 期
study to access effectiveness of new drug therapy (aspirin,atorvastatin and nicorandil) in covid-19CTRI/2021/04/032648Dr Ambudhar Sharma
进行中（未招募）
1 期
Investigation of efficacy and safety of three dose levels of subcutaneous semaglutide once daily versus placebo in subjects with non-alcoholic steatohepatitis.on-alcoholic steatohepatitisMedDRA version: 19.0Level: PTClassification code 10053219Term: Non-alcoholic steatohepatitisSystem Organ Class: 10019805 - Hepatobiliary disordersEUCTR2016-000685-39-FRovo Nordisk A/S372
进行中（未招募）
1 期
Investigation of efficacy and safety of three dose levels of subcutaneous semaglutide once daily versus placebo in subjects with non-alcoholic steatohepatitis.on-alcoholic steatohepatitisMedDRA version: 22.0Level: PTClassification code 10053219Term: Non-alcoholic steatohepatitisSystem Organ Class: 10019805 - Hepatobiliary disordersEUCTR2016-000685-39-NLovo Nordisk A/S288
进行中（未招募）
1 期
Investigation of efficacy and safety of three dose levels of subcutaneous semaglutide once daily versus placebo in subjects with non-alcoholic steatohepatitison-alcoholic steatohepatitisMedDRA version: 20.1Level: PTClassification code 10053219Term: Non-alcoholic steatohepatitisSystem Organ Class: 10019805 - Hepatobiliary disordersEUCTR2016-000685-39-BGovo Nordisk A/S320